ATE257834T1 - Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe - Google Patents

Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe

Info

Publication number
ATE257834T1
ATE257834T1 AT00938160T AT00938160T ATE257834T1 AT E257834 T1 ATE257834 T1 AT E257834T1 AT 00938160 T AT00938160 T AT 00938160T AT 00938160 T AT00938160 T AT 00938160T AT E257834 T1 ATE257834 T1 AT E257834T1
Authority
AT
Austria
Prior art keywords
heterocyclic
melatonergenic
actives
aminopyrrolidone derivatives
aminopyrrolidone
Prior art date
Application number
AT00938160T
Other languages
English (en)
Inventor
Katherine S Takaki
Guanglin Luo
Stephen R Bertenshaw
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE257834T1 publication Critical patent/ATE257834T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Cosmetics (AREA)
  • Hydrogenated Pyridines (AREA)
AT00938160T 1999-06-30 2000-06-06 Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe ATE257834T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14189499P 1999-06-30 1999-06-30
PCT/US2000/015478 WO2001002392A1 (en) 1999-06-30 2000-06-06 Heterocyclic aminopyrrolidine derivatives as melatonergic agents

Publications (1)

Publication Number Publication Date
ATE257834T1 true ATE257834T1 (de) 2004-01-15

Family

ID=22497702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00938160T ATE257834T1 (de) 1999-06-30 2000-06-06 Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe

Country Status (13)

Country Link
US (1) US6211225B1 (de)
EP (1) EP1189900B1 (de)
JP (2) JP4767463B2 (de)
AT (1) ATE257834T1 (de)
AU (1) AU763963B2 (de)
CA (1) CA2376949C (de)
DE (1) DE60007745T2 (de)
DK (1) DK1189900T3 (de)
ES (1) ES2213022T3 (de)
PE (1) PE20010327A1 (de)
PT (1) PT1189900E (de)
UY (1) UY26226A1 (de)
WO (1) WO2001002392A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569894B1 (en) 2001-10-04 2003-05-27 Bristol-Myers Squibb Company Arylalkylbenzofuran derivatives as melatonergic agents
US6737431B2 (en) 2002-03-12 2004-05-18 Bristol-Myers Squibb Company Benzoxazole derivatives as novel melatonergic agents
BR0313405A (pt) 2002-08-12 2005-07-12 Takeda Pharmaceutical Compostos, métodos para preparar um composto e para prevenir e/ou tratar câncer, prodroga, medicamento, modulador do receptor de androgênio, agente para prevenir e/ou tratar hipogonadismo ou pertubação climatérica masculina, osteoporose e câncer, e, uso de um composto
BRPI0610037A2 (pt) * 2005-04-22 2010-05-25 Wyeth Corp derivados de dihidrobenzofurano e uso dos mesmos
WO2006116136A1 (en) * 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
EP2029564A4 (de) * 2006-05-22 2010-01-13 Vanda Pharmaceuticals Inc Behandlung für depressionserkrankungen
BRPI0810997A2 (pt) * 2007-04-26 2015-01-27 Takeda Pharmaceutical Composto, pró-droga, composição farmacêutica, método para prevenir ou tratar distúrbio do sono em um mamífero, e, uso do composto
ES2331276B1 (es) * 2007-10-25 2010-10-21 Ferrer Internacional, S.A. Compuestos de fenilpirrolidina.
EP2266975A1 (de) * 2009-06-15 2010-12-29 Ferrer Internacional, S.A. 1-(2-Alkyl-2,3-dihydrobenzofuran-4-yl)pyrrolidin-3-ylaminacyl-Verbindungen
ES2897671T3 (es) 2012-01-26 2022-03-02 Vanda Pharmaceuticals Inc Sincronización del ritmo circadiano desincrónico del cortisol
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
PT2925745T (pt) 2012-11-29 2018-08-08 Chemocentryx Inc Antagonistas de cxcr7
CN105142630A (zh) 2012-12-18 2015-12-09 万达制药公司 昼夜节律紊乱的治疗
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
BR102016024814A2 (pt) 2016-10-24 2018-05-08 Aché Laboratórios Farmacêuticos S.A. composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono
BR112021011222A2 (pt) 2018-12-12 2021-08-24 Chemocentryx, Inc. Inibidores de cxcr7 para o tratamento de câncer
CN109574970A (zh) * 2018-12-27 2019-04-05 上海毕得医药技术有限公司 一种5-溴苯并二氢吡喃的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518273A (en) * 1966-08-03 1970-06-30 Warner Lambert Pharmaceutical Benzopyranquinolinol derivatives and process for their production
US3485835A (en) * 1968-04-10 1969-12-23 Haessle Ab 2-benzoyl-3-tertiaryamino alkoxy benzofuran derivatives
US5071875A (en) 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
FR2674524B1 (fr) 1991-03-25 1993-05-21 Adir Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2680366B1 (fr) 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2689124A1 (fr) 1992-03-27 1993-10-01 Adir Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5449683A (en) 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin
GB9326192D0 (en) 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9407919D0 (en) 1994-04-21 1994-06-15 Glaxo Group Ltd Chemical compounds
FR2725985B1 (fr) 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
TR199802318T2 (xx) 1996-05-14 1999-03-22 Glaxo Group Limited Kronobiyolojik maddeler olarak benzofuranlar ve benzopiranlar.
NZ335910A (en) * 1996-12-10 2000-11-24 Bristol Myers Squibb Co Benzodioxole, benzofuran, dihydrobenzofuran and benzodioxane melatonergic agents useful in treating sleep disorders and circadian rhthym related disorders
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
JP2011137043A (ja) 2011-07-14
JP4767463B2 (ja) 2011-09-07
WO2001002392A1 (en) 2001-01-11
AU763963B2 (en) 2003-08-07
EP1189900B1 (de) 2004-01-14
UY26226A1 (es) 2001-01-31
DE60007745D1 (de) 2004-02-19
PE20010327A1 (es) 2001-06-10
AU5324000A (en) 2001-01-22
CA2376949C (en) 2009-05-26
EP1189900A1 (de) 2002-03-27
EP1189900A4 (de) 2002-07-31
JP2003503492A (ja) 2003-01-28
PT1189900E (pt) 2004-05-31
US6211225B1 (en) 2001-04-03
ES2213022T3 (es) 2004-08-16
DK1189900T3 (da) 2004-04-26
DE60007745T2 (de) 2005-03-10
JP5248647B2 (ja) 2013-07-31
CA2376949A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
ATE257834T1 (de) Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe
DE60110262D1 (de) Thiazol und oxazol-derivate als aktivatoren von menschlichen peroxisom proliferator aktivierten rezeptoren
DE60020812D1 (de) Heteroaryl-substituierte chinolin-2-on derivate verwendbar als antikrebsmittel
TR200201364T2 (tr) Yeni bileşikler.
TR199901674T2 (de)
CO5200832A1 (es) Derivados de acidos heterociclicos, o una sal farmaceuticamente aceptable de los mismos, que son agentes antidiabeticos y antiobesidad
ATE271039T1 (de) Harnstoffderivate wirksam als muscarinrezeptor- antagonisten
CO5210884A1 (es) DERIVADOS DE 5H-TIAZOLO[3,2-a] PIRIMIDINA
TR199800436A2 (xx) Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�.
ATE302775T1 (de) Carbolinderivate
DE60018372D1 (de) Oralzusammensetzung als mikroemulsion von silybin
SE9702773D0 (sv) Novel compounds
DE60121461D1 (de) Kondensierte pyridoindolderivate
ATE346067T1 (de) Carbolinderivate
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
ATE275143T1 (de) Verbindungen
DE60112960D1 (de) Kondensierte pyridoindolderivate
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
YU44301A (sh) 5ht1 antagonisti za antidepresantnu terapiju
CY1105373T1 (el) Ισοκινολινυλικα καρβοξαμιδια και η χρηση τους ως αντισπαστικα
ATE337320T1 (de) Indolderivate als pde5-inhibitoren
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
CO5261576A1 (es) Compuestos
AR021094A1 (es) Compuestos heterociclicos inhibidores de la fosfodiesterasa iv y su uso para el tratamiento de enfermedades inflamatorias

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1189900

Country of ref document: EP